Total mesopancreas excision for pancreatic head cancer: analysis of 120 cases

Wenguang Wu1, Xu'an Wang1, Xiangsong Wu1

  • 1Department of General Surgery and Laboratory of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; Institute of Biliary Tract Disease, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Abstract

Insights

Total mesopancreas excision (TMpE) is a safe and feasible surgical approach for pancreatic head cancer. This technique effectively increases the rate of R0 resection, improving patient outcomes.

Area of Science:

  • Surgical Oncology
  • Gastrointestinal Surgery

Background:

  • Pancreatic head cancer presents significant treatment challenges.
  • Complete tumor removal is crucial for improving patient survival rates.

Purpose of the Study:

  • To assess the feasibility and safety of total mesopancreas excision (TMpE) for pancreatic head cancer.
  • To evaluate the impact of TMpE on achieving R0 resection rates.

Main Methods:

  • Retrospective analysis of clinical and pathological data.
  • 120 patients with pancreatic head cancer underwent TMpE between May 2010 and January 2014.

Main Results:

  • Mean operative time was 275.0±50.2 minutes; average blood loss was 390.0±160.5 mL.
  • 45 patients experienced post-operative complications; no peri-operative deaths occurred.
  • 86 patients (71.6%) achieved R0 resection, indicating complete tumor removal.

Conclusions:

  • TMpE is a safe and feasible surgical option for pancreatic head cancer.
  • TMpE significantly enhances the likelihood of achieving R0 resection.

Related Concept Videos